Soltis Investment Advisors’s Clene CLNN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-5,476
Closed -$32.5K 299
2023
Q4
$32.5K Sell
5,476
-5,470
-50% -$47.7K ﹤0.01% 283
2023
Q3
$109K Hold
10,946
0.01% 257
2023
Q2
$193K Hold
10,946
0.02% 251
2023
Q1
$247K Hold
10,946
0.03% 229
2022
Q4
$219K Hold
10,946
0.03% 230
2022
Q3
$613K Hold
10,946
0.09% 149
2022
Q2
$552K Hold
10,946
0.08% 155
2022
Q1
$863K Hold
10,946
0.12% 135
2021
Q4
$898K Hold
10,946
0.13% 132
2021
Q3
$1.5M Buy
+10,946
New +$1.87M 0.23% 91

Other funds holding CLNN

Soltis Investment Advisors's CLNN Position: Q1 2024 in Review

Soltis Investment Advisors sold out of Clene (CLNN) in Q1 2024, closing a stake of 5,476 shares — an estimated $32.5K sold.

Soltis Investment Advisors first reported a position in CLNN in Q3 2021 and held it in 10 quarters. The position peaked at $1.5M in Q3 2021. 43 funds tracked by Wall St. Rank hold CLNN as of Q1 2024.

  • Soltis Investment Advisors reported no remaining Clene position as of Q1 2024 after selling out during the quarter.
  • Soltis Investment Advisors sold 5,476 Clene shares in Q1 2024, an estimated $32.5K.
  • Soltis Investment Advisors first reported a position in Clene in Q3 2021 and held it in 10 quarters.
  • Soltis Investment Advisors's Clene position peaked at $1.5M in Q3 2021.
  • 43 funds tracked by Wall St. Rank held Clene as of Q1 2024.

Based on Soltis Investment Advisors's 13F filing for Q1 2024, filed 29 Apr 2024.